The Frequency of Central Sensitization in Patients With Chronic Musculoskeletal Pain
Unknown statusNCT04765280
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Central sensitization is as increased response to normal or sub-threshold stimuli of central nervous system and its close relationship with in many musculoskeletal diseases with chronic pain has been demonstrated in several studies. However, the effect of central sensitization on disability in these patients is not fully known. In this study, it was aimed to investigate the frequency of central sensitization and its effect on patients with chronic musculoskeletal pain who were admitted to physical medicine and rehabilitation outpatient clinics.
Study details
- Official title
- Evaluation of the Relationship Between Central Sensitization and Disability in Patients With Chronic Musculoskeletal Pain in Physical Medicine and Rehabilitation Clinic.
- Conditions
- Central Sensitisation
- Chronic Musculoskeletal Disease
- Chronic Pain
- Interventions
- Diagnostic test: Central sensitization inventory
- Other: Short form-36
- Other: Istanbul Low Back Pain Disability Index
- Other: Disabilities of the Arm, Shoulder and Hand (DASH)
- Other: Neck Pain and Disability scale
- Other: Knee Injury and Osteoarthritis Outcome Score
- Other: Western Ontario and McMaster Universities Arthritis Index
- Other: Visual analogue scale
- Sponsor
- Marmara University
- Start date
- 2021-01-01
- Primary completion
- 2023-03-01
- Sex
- All
- Age range
- from 18 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Have musculoskeletal pain that lasts for at least 3 months * Accepting to participate in the study Exclusion Criteria: * Have rheumatic disease
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04765280